Company intelligence / Profile preview
Inmunotek
Alcalá de Henares / San Sebastián de los Reyes, Madrid, Spaininmunotek.com ↗
- Ownership
- Private
- Employees
- ~332
- Development stage
- Phase 3
01
Overview
Inmunotek develops, manufactures, and markets diagnostic and therapeutic products for allergy and immunology. Its products are approved by the Spanish Drug Agency and several international agencies. The company has received multiple awards for innovation and business growth. It operates globally with a broad product portfolio focused on allergy immunotherapy, infectious disease vaccines, cancer vaccines, diagnostics, and medical devices. Specific clinical trial results are not detailed in public sources.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Therapeutic vaccines (allergy, infectious diseases, cancer)ImmunotherapyMedical devices
- Industry
- Biotech
02
Drug pipeline
55 assets54 more assets in the full pipeline.
Beyond the preview
Go deeper on Inmunotek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inmunotek.